📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Montelukast reduces grey matter abnormalities and functional deficits in a mouse model of inflammation-induced encephalopathy of prematurity. (2022)

First Author: Yates AG

Attributed to: The Developing Brain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12974-022-02625-5

PubMed Identifier: 36309753

Publication URI: http://europepmc.org/abstract/MED/36309753

Type: Journal Article/Review

Volume: 19

Parent Publication: Journal of neuroinflammation

Issue: 1

ISSN: 1742-2094